antibodies
-
The biggest tragedy of pet ownership is that they just don’t live long enough. Thankfully scientists are working on that, with a new cancer vaccine for dogs that almost doubles their survival rates in the face of certain types of the disease.
-
A drug used to treat asthma has been shown to substantially reduce the risk of potentially life-threatening reactions in people aged one and older with multiple common food allergies, including peanuts, following accidental exposure.
-
A universal snake-bite antivenom is within reach, with scientists making an antibody that protects against lethal strikes from a range of elapids. No snakes or ‘donor animals' were needed to produce the antivenom, making it sustainable and scalable.
-
Researchers found that getting a multidose vaccine in different arms may improve the body’s immune response to the vaccine by up to four-fold. While they exclusively looked at the COVID-19 vaccine, they suspect this effect may be seen with others.
-
Researchers have used radioactive monoclonal antibodies to find and destroy a particularly lethal form of pancreatic cancer. The combination of diagnostics and therapeutics could lead to earlier detection and more effective treatment of the disease.
-
Researchers have found that an intranasal drug, currently being tested as an MS treatment, reduced brain inflammation and improved cognition in mice with Alzheimer’s disease, independent of the amount of beta-amyloid plaques present.
-
Researchers are close to human clinical trials to test the safety and efficacy of vaccines to prevent heroin and fentanyl overdoses. If approved, they could revolutionize the treatment of opioid addiction and reduce deaths from overdose.
-
Researchers have developed an antibody that targets the opioid fentanyl and its derivatives, reversing overdose better than currently available treatments. The novel therapy could be a more effective way of treating life-threatening opioid overdoses.
-
Metastatic cancer accounts for up to 90% of all cancer deaths in the US annually. Now, researchers have trialed a first-of-its-kind monoclonal antibody drug that inhibits the process by which cancer cells spread, and results are promising.
-
Humans have done remarkably well in evolutionary terms, but one design flaw has to be our inability to replace lost teeth throughout our lives. Now, scientists believe they have the antibody treatment to do just that, and it could be available by 2030.
-
When a person with rheumatoid arthritis receives healthy antibodies intravenously, it can reduce inflammation. Researchers have, for the first time, discovered the molecular pathways that underlie this effect, paving the way for new treatments.
-
A Phase 3 clinical trial of the drug donanemab has shown it can significantly slow cognitive and functional decline in people with early-stage Alzheimer’s disease, compared with existing treatments.
Load More